Article thumbnail

Novel Chalcone-Based Fluorescent Human Histamine H3 Receptor Ligands as Pharmacological Tools

By Miriam Tomasch, J. Stephan Schwed, Lilia Weizel and Holger Stark
Get PDF (0 MB)

Abstract

Novel fluorescent chalcone-based ligands at human histamine H3 receptors (hH3R) have been designed, synthesized, and characterized. Compounds described are non-imidazole analogs of ciproxifan with a tetralone motif. Tetralones as chemical precursors and related fluorescent chalcones exhibit affinities at hH3R in the same concentration range like the reference antagonist ciproxifan (hH3R pKi value of 7.2). Fluorescence characterization of our novel ligands shows emission maxima about 570 nm for yellow fluorescent chalcones and ≥600 nm for the red fluorescent derivatives. Interferences to cellular autofluorescence could be excluded. All synthesized chalcone compounds could be used to visualize hH3R proteins in stably transfected HEK-293 cells using confocal laser scanning fluorescence microscopy. These novel fluorescent ligands possess high potential to be used as pharmacological tools for hH3R visualization in different tissues

Topics: Neuroscience
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3312100
Provided by: PubMed Central
Downloaded from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3312100

Suggested articles

Citations

  1. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.
  2. (1996). [125I]iodoproxyfanandrelatedcompounds:areversibleradioligandand novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.
  3. (1976). A rapid and sensitive method for the quantifi-cation of microgram quantities of protein utilizing the principle of protein-dye binding.
  4. (1851). About the theory of the formation of ethers.
  5. and Stark,H.(2001).Influenceof imidazole replacement in different structural classes of histamine H3-receptor antagonists.
  6. (2003). Application of ionic liquid halide nucleophilicity for the cleavage of ethers: a green protocolfortheregenerationofphenols from ethers.
  7. (2012). C,76.79; H,8.22; N,6.18. Found: C,76.71; H,8.47;
  8. (2012). Chalcone-based fluorescent hH3 receptor ligands
  9. (2012). Chalcone-based fluorescent hH3 receptor ligands TableA1 | Fluorescence images of fluorescent compounds.
  10. (2000). Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit. Naunyn SchmiedebergsArch.
  11. (2006). Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
  12. (2004). Comparison of effect of selected synthetic chalcone analogues on mitochondrial outer membrane determined by fluorescence microscopy.
  13. (2012). Compound Cell line Ligand image DAPI image Overlay of ligand and DAPI image 3h H 3-HEK-293 3 HEK-293 4h H 3-HEK-293 4 HEK-293 5h H 3-HEK-293 5 HEK-293 (Continued) Frontiers in Systems Neuroscience www.frontiersin.org
  14. (1995). DAPI: a DNAspecific fluorescent probe.
  15. (2009). Detection of low level histamine H3 receptor occupancy by autoradiography.
  16. (2000). Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain.
  17. (2006). Ether derivatives of 3-piperidinopropan1-ol as non-imidazole histamine H3 receptorligands.Bioorg.Med.Chem.
  18. (2006). Fluorescent benzofuran histamine H3 receptor antagonists with subnanomolar potency.
  19. (2008). Fluorescent GPCR ligands as new tools in pharmacology.
  20. (1998). Groundand excited-state properties of some 3,4-dihydro-1-(2-p-substituted benzylidene)naphtalenones: substituent and environmental effects.
  21. (2007). Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
  22. (2011). Histamine H1,H 3 and H4 receptors are involved in pruritus.
  23. (2008). Histamine H3 receptor antagonists go to clinics.
  24. (2012). Histamine receptor subtypes: a century ofrationaldrugdesign.Front.Biosci.
  25. HRMS: calc.: 551.32682; found: 551.32618.
  26. (2010). Kojic acid derivatives as histamine H3 receptor ligands.
  27. (2006). non-imidazole histamine H3 receptor ligands with nanomolar affinities.
  28. (2012). Novel chalconebased fluorescent human histamine H3 receptor ligands as pharmacological tools.
  29. (2008). Piperidine variations in search for non-imidazole histamine H3 receptor ligands.
  30. (2011). Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
  31. (2004). Role of the histamine system in nefopam-induced antinociception in mice.
  32. (2005). Search for histamineH3 receptorantagonistswith combined inhibitory potency at Nτ-methyltransferase: ether derivatives.
  33. (2010). Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties.
  34. (2012). Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  35. (2008). The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.
  36. (1990). Three histamine receptors (H1,H 2 and H3) visualized in the brain of human andnon-humanprimates.BrainRes.
  37. (2009). Use of the H3 receptor antagonist radioligand[3H]-A-349821toreveal invivoreceptoroccupancyof cognition enhancing H3 receptor antagonists.Br.J.Pharmacol.157,139–149.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.